Di Nicola M - Search Results

1

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial.

Ferreri AJ, Donadoni G, Cabras MG, Patti C, Mian M, Zambello R, Tarella C, Di Nicola M, D'Arco AM, Doa G, Bruno-Ventre M, Assanelli A, Foppoli M, Citterio G, Fanni A, Mulè A, Caligaris-Cappio F, Ciceri F. Ferreri AJ, et al. Among authors: di nicola m. J Clin Oncol. 2015 Nov 20;33(33):3903-10. doi: 10.1200/JCO.2015.61.1236. Epub 2015 Aug 17. J Clin Oncol. 2015. PMID: 26282634 Clinical Trial.

2

Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.

Gianni AM, Bregni M, Siena S, Magni M, Di Nicola M, Lombardi F, Tarella C, Pileri A, Bonadonna G. Gianni AM, et al. Among authors: di nicola m. J Clin Oncol. 1992 Dec;10(12):1955-62. doi: 10.1200/JCO.1992.10.12.1955. J Clin Oncol. 1992. PMID: 1280674

3

[Clinical use of hematopoietic growth factors].

Gianni AM, Bregni M, Siena S, Tarella C, DiNicola M, Bonadonna G. Gianni AM, et al. Haematologica. 1991 Jun;76 Suppl 3:3-10. Haematologica. 1991. PMID: 1752526 Review. Italian. No abstract available.

4

High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.

Gianni AM, Siena S, Bregni M, Lombardi F, Gandola L, Di Nicola M, Magni M, Peccatori F, Valagussa P, Bonadonna G. Gianni AM, et al. Among authors: di nicola m. Ann Oncol. 1993 Dec;4(10):889-91. doi: 10.1093/oxfordjournals.annonc.a058399. Ann Oncol. 1993. PMID: 7509620 Free article.

5

Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors.

Siena S, Bregni M, Di Nicola M, Ravagani F, Peccatori F, Gandola L, Lombardi F, Tarella C, Bonadonna G, Gianni AM. Siena S, et al. Among authors: di nicola m. Ann Oncol. 1994 Dec;5(10):935-41. doi: 10.1093/oxfordjournals.annonc.a058733. Ann Oncol. 1994. PMID: 7696166 Free article.

6

Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.

Bregni M, Siena S, Di Nicola M, Dodero A, Peccatori F, Ravagnani F, Danesini G, Laffranchi A, Bonadonna G, Gianni AM. Bregni M, et al. Among authors: di nicola m. J Clin Oncol. 1996 Feb;14(2):628-35. doi: 10.1200/JCO.1996.14.2.628. J Clin Oncol. 1996. PMID: 8636780

7

Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the miltenyi CD34+ cell sorting system.

Di Nicola M, Siena S, Corradini P, Bregni M, Milanesi M, Magni M, Ruffini PA, Ravagnani F, Tarella C, Gianni AM. Di Nicola M, et al. Bone Marrow Transplant. 1996 Dec;18(6):1117-21. Bone Marrow Transplant. 1996. PMID: 8971381

8

High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.

Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, Gandola L, Tarella C, Pileri A, Ravagnani F, Valagussa P, Bonadonna G. Gianni AM, et al. Among authors: di nicola m. N Engl J Med. 1997 May 1;336(18):1290-7. doi: 10.1056/NEJM199705013361804. N Engl J Med. 1997. PMID: 9113932 Free article. Clinical Trial.

9

Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.

Gianni AM, Siena S, Bregni M, Di Nicola M, Orefice S, Cusumano F, Salvadori B, Luini A, Greco M, Zucali R, Rilke F, Zambetti M, Valagussa P, Bonadonna G. Gianni AM, et al. Among authors: di nicola m. J Clin Oncol. 1997 Jun;15(6):2312-21. doi: 10.1200/JCO.1997.15.6.2312. J Clin Oncol. 1997. PMID: 9196145 Clinical Trial.

10

Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.

Magni M, Di Nicola M, Devizzi L, Matteucci P, Lombardi F, Gandola L, Ravagnani F, Giardini R, Dastoli G, Tarella C, Pileri A, Bonadonna G, Gianni AM. Magni M, et al. Among authors: di nicola m. Blood. 2000 Aug 1;96(3):864-9. Blood. 2000. PMID: 10910898 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

649 results

Search Page